Bharat Biotech's corona vaccine Covaxin 81% effective
The trials involved 25,800 participants and was conducted in partnership with the Indian government's medical research body.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Government | India Health | Partnerships | Pharmaceuticals | Research | Vaccines